Annual CFO
-$55.66 M
+$8.10 M+12.71%
31 December 2023
Summary:
PMV Pharmaceuticals annual cash flow from operations is currently -$55.66 million, with the most recent change of +$8.10 million (+12.71%) on 31 December 2023. During the last 3 years, it has fallen by -$22.92 million (-70.00%). PMVP annual CFO is now -266.70% below its all-time high of -$15.18 million, reached on 31 December 2018.PMVP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$16.84 M
-$15.24 M-953.75%
30 September 2024
Summary:
PMV Pharmaceuticals quarterly cash flow from operations is currently -$16.84 million, with the most recent change of -$15.24 million (-953.75%) on 30 September 2024. Over the past year, it has dropped by -$1.18 million (-7.54%). PMVP quarterly CFO is now -953.75% below its all-time high of -$1.60 million, reached on 30 June 2024.PMVP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$46.71 M
-$1.18 M-2.59%
30 September 2024
Summary:
PMV Pharmaceuticals TTM cash flow from operations is currently -$46.71 million, with the most recent change of -$1.18 million (-2.59%) on 30 September 2024. Over the past year, it has increased by +$12.19 million (+20.70%). PMVP TTM CFO is now -473.92% below its all-time high of -$8.14 million, reached on 31 March 2020.PMVP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMVP Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.7% | -7.5% | +20.7% |
| 3 y3 years | -70.0% | -35.8% | -4.1% |
| 5 y5 years | -266.7% | - | - |
PMVP Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -70.0% | +12.7% | -953.8% | +6.4% | -4.1% | +26.8% |
| 5 y | 5 years | -266.7% | +12.7% | -953.8% | +6.4% | -473.9% | +26.8% |
| alltime | all time | -266.7% | +12.7% | -953.8% | +6.4% | -473.9% | +26.8% |
PMV Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.84 M(+953.8%) | -$46.71 M(+2.6%) |
| June 2024 | - | -$1.60 M(-90.1%) | -$45.53 M(-19.9%) |
| Mar 2024 | - | -$16.18 M(+33.9%) | -$56.83 M(+2.1%) |
| Dec 2023 | -$55.66 M(-12.7%) | -$12.09 M(-22.8%) | -$55.66 M(-5.5%) |
| Sept 2023 | - | -$15.66 M(+21.4%) | -$58.90 M(-1.8%) |
| June 2023 | - | -$12.90 M(-14.1%) | -$60.00 M(-1.3%) |
| Mar 2023 | - | -$15.01 M(-2.0%) | -$60.77 M(-4.7%) |
| Dec 2022 | -$63.76 M | -$15.32 M(-8.6%) | -$63.76 M(+5.5%) |
| Sept 2022 | - | -$16.76 M(+22.5%) | -$60.46 M(+7.8%) |
| June 2022 | - | -$13.68 M(-24.0%) | -$56.10 M(+8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$18.00 M(+49.6%) | -$51.66 M(+10.9%) |
| Dec 2021 | -$46.57 M(+42.2%) | -$12.03 M(-3.0%) | -$46.57 M(+3.8%) |
| Sept 2021 | - | -$12.40 M(+34.2%) | -$44.85 M(+12.6%) |
| June 2021 | - | -$9.24 M(-28.4%) | -$39.85 M(+6.3%) |
| Mar 2021 | - | -$12.90 M(+25.1%) | -$37.51 M(+14.6%) |
| Dec 2020 | -$32.74 M(+48.4%) | -$10.31 M(+39.5%) | -$32.74 M(+46.0%) |
| Sept 2020 | - | -$7.39 M(+7.2%) | -$22.43 M(+49.2%) |
| June 2020 | - | -$6.90 M(-15.3%) | -$15.03 M(+84.7%) |
| Mar 2020 | - | -$8.14 M | -$8.14 M |
| Dec 2019 | -$22.07 M(+45.4%) | - | - |
| Dec 2018 | -$15.18 M | - | - |
FAQ
- What is PMV Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals annual CFO year-on-year change?
- What is PMV Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals quarterly CFO year-on-year change?
- What is PMV Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals TTM CFO year-on-year change?
What is PMV Pharmaceuticals annual cash flow from operations?
The current annual CFO of PMVP is -$55.66 M
What is the all time high annual CFO for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high annual cash flow from operations is -$15.18 M
What is PMV Pharmaceuticals annual CFO year-on-year change?
Over the past year, PMVP annual cash flow from operations has changed by +$8.10 M (+12.71%)
What is PMV Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of PMVP is -$16.84 M
What is the all time high quarterly CFO for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high quarterly cash flow from operations is -$1.60 M
What is PMV Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, PMVP quarterly cash flow from operations has changed by -$1.18 M (-7.54%)
What is PMV Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of PMVP is -$46.71 M
What is the all time high TTM CFO for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high TTM cash flow from operations is -$8.14 M
What is PMV Pharmaceuticals TTM CFO year-on-year change?
Over the past year, PMVP TTM cash flow from operations has changed by +$12.19 M (+20.70%)